Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_assertion type Assertion NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_head.
- NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_assertion wasGeneratedBy ECO_0000203 NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_provenance.
- NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_assertion wasDerivedFrom befree-2016 NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_provenance.
- NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_assertion SIO_000772 11315626 NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_provenance.
- NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_assertion evidence source_evidence_literature NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_provenance.
- NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_provenance.